SANC00391



3β,16β,17α-Trihydroxy-cholest-5-en-22-one 16-O-(2-O-3,4-dimethoxybenzoyl-β-d-xylopyranosyl)-(1→3)-(2-O-acetyl-α-l-arabinopyranoside)





C48H70O16









145075-82-7



SMILES:

[H][C@@]7(O[C@H]4C[C@@]3([H])[C@]2([H])CC=C1C[C@@H](O)CC[C@]1(C)[C@@]2([H])CC[C@]3(C)[C@@]4(O)[C@H](C)C(=O)CCC(C)C)OC[C@H](O)[C@H](O[C@]5([H])OC[C@@H](O)[C@H](O)[C@H]5OC(=O)c6ccc(OC)c(OC)c6)[C@H]7OC(C)=O





References

  • Kubo et al. (1992) Acylated cholestane glycosides from the bulbs of Ornithogalum saundersiae

  • Mimaki et al. (1997) Cholestane glycosides with potent cytostatic activities on various tumor cells from Ornithogalum saundersiae bulbs

  • Classifications

  • Cholestane

  • Glycoside

  • Other Names

  • Cholest-5-En-22-One, 16-[[2-O-Acetyl-3-O-[2-O-(3,4-Dimethoxybenzoyl)-[Beta]-D-Xylopyranosyl]-[Alpha]-L-Arabinopyranosyl]Oxy]-3,17-Dihydroxy-, (3[Beta],16[Beta])-
  • 3[Beta],16[Beta],17[Alpha]-Trihydroxy-Cholest-5-En-22-One 16-O-(2-O-3,4-Dimethoxybenzoyl-[Beta]-D-Xylopyranosyl)-(1[To]3)-(2-O-Acetyl-[Alpha]-L-Arabinopyranoside)

  • Source Organisms

  • Ornithogalum saundersiae

    Compound Uses

  • Cyclic AMP phosphodiesterase inhibitor
  • Cytostatic activity against HL-60 leukemia cells